Compatibility /100
63/100
High potentialWhy talk
- Legit.Health has strong traction in the same sector: CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships Cromodata can learn from or tap.
- Same sector (HealthTech): peer learning on regulation, pricing and investors; Cromodata works on Health data / real-world data, Legit.Health on AI in dermatology (medical device).
- Cromodata likely needs a first foreign market — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
8.8 / 25 pts
Legit.Health can help Cromodata.
- Cromodata likely needs a first foreign market — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).
Market bridge
3.8 / 15 pts
Distant markets.
- Legit.Health is based in Spain (Europe): a landing pad on another continent, both ways.
Customer potential
34.0 / 40 pts
Strong customer or channel potential.
- Legit.Health has strong traction in the same sector: CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships Cromodata can learn from or tap.
Sector synergy
11.3 / 15 pts
Same sector: peers.
- Same sector (HealthTech): peer learning on regulation, pricing and investors; Cromodata works on Health data / real-world data, Legit.Health on AI in dermatology (medical device).
Stage complementarity
5.0 / 5 pts
Strong mentoring / investor-intro potential.
- Legit.Health has raised about $5.7M — investor introductions are realistic.
- Legit.Health (Seed) is one step ahead of Cromodata (Pre-seed) — the freshest playbook for Cromodata's next round.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Customers”: Needs ↔ offers 25, Market bridge 15, Customer potential 40, Sector synergy 15, Stage complementarity 5. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 60/100 — high from 50, medium from 36.

